Arai et al. performed a large-scale molecular profiling study of 14,287 CRC cases and discovered that CD47-high tumors were markedly enriched for CMS1 and CMS4 subtypes, both linked to immune activation and heightened immune cell infiltration [93]. Here, CD47 is linked to colorectal carcinoma.